Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CITALOPRAM HYDROBROMIDE Cause Conjunctivitis? 11 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Conjunctivitis have been filed in association with CITALOPRAM HYDROBROMIDE (Citalopram Hydrobromide). This represents 0.0% of all adverse event reports for CITALOPRAM HYDROBROMIDE.

11
Reports of Conjunctivitis with CITALOPRAM HYDROBROMIDE
0.0%
of all CITALOPRAM HYDROBROMIDE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Conjunctivitis From CITALOPRAM HYDROBROMIDE?

Of the 11 reports, 3 (27.3%) required hospitalization.

Is Conjunctivitis Listed in the Official Label?

Yes, Conjunctivitis is listed as a known adverse reaction in the official FDA drug label for CITALOPRAM HYDROBROMIDE.

What Other Side Effects Does CITALOPRAM HYDROBROMIDE Cause?

Toxicity to various agents (3,531) Completed suicide (2,319) Drug abuse (1,792) Drug ineffective (1,729) Fatigue (1,431) Overdose (1,377) Drug interaction (1,366) Headache (1,339) Nausea (1,258) Foetal exposure during pregnancy (1,154)

What Other Drugs Cause Conjunctivitis?

DUPILUMAB (5,270) ADALIMUMAB (457) METHOTREXATE (385) ETANERCEPT (306) PREDNISONE (250) SECUKINUMAB (237) RITUXIMAB (222) SULFAMETHOXAZOLE\TRIMETHOPRIM (218) INFLIXIMAB (212) LAMOTRIGINE (199)

Which CITALOPRAM HYDROBROMIDE Alternatives Have Lower Conjunctivitis Risk?

CITALOPRAM HYDROBROMIDE vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CITALOPRAM HYDROBROMIDE vs CITICOLINE CITALOPRAM HYDROBROMIDE vs CITRIC ACID CITALOPRAM HYDROBROMIDE vs CITRIC ACID\LACTIC ACID, L-\POTASSIUM CITALOPRAM HYDROBROMIDE vs CLADRIBINE

Related Pages

CITALOPRAM HYDROBROMIDE Full Profile All Conjunctivitis Reports All Drugs Causing Conjunctivitis CITALOPRAM HYDROBROMIDE Demographics